Literature DB >> 25788184

Potential of Gd-EOB-DTPA-enhanced MR imaging for evaluation of bile duct ligation-induced liver injury in rabbits.

Ying Ding1, Sheng-Xiang Rao, Caizhong Chen, Renchen Li, Meng-Su Zeng.   

Abstract

OBJECTIVES: The aim of this study was to evaluate the potential of gadoxetic acid (Gd-EOB-DTPA)-enhanced MRI for assessment of bile duct ligation (BDL)-induced chelostatic liver injury in an animal model by T1 relaxation time measurements and first-pass perfusion analyses.
MATERIALS AND METHODS: Twenty-four rabbits were classified into three groups as follows: control group (N group), n = 8; BDL group studied on the 5th postoperative day (BDL-5d group), n = 8; BDL group studied on the 14th postoperative day (BDL-14d group), n = 8. A dual flip angle three-dimensional gradient echo sequence with volumetric interpolated breath-hold examination was performed before and at 20 min [hepatobiliary phase (HBP)] after Gd-EOB-DTPA administration. Besides, early dynamic contrast-enhanced MRI was performed for 4.32 min with a temporal resolution of 2.2 s. T1 relaxation times of liver parenchyma were measured and perfusion parameters were calculated.
RESULTS: Dilatation of intra-hepatic bile duct was found only in the BDL-14d group. HBP T1 relaxation times of the BDL-5d and BDL-14d groups were significantly prolonged (p < 0.001) and the enhancement slope percentage of BDL-5d and BDL-14d groups were significantly lowered in comparison with that of the N group (p < 0.001). There were no differences between the BDL-5d group and the BDL-14d group for HBP T1 relaxation times and the enhancement slope percentage (p > 0.05). Area under the receiver operating characteristic curve of HBP T1 relaxation time and the enhancement slope percentage for the selection of chelostatic liver were 0.98 and 0.92 for the BDL-5d group, and 0.96 and 0.98 for the BDL-14d group, respectively.
CONCLUSIONS: HBP T1 relaxation time measurement in combination with first-pass enhancement slope percentage withhold promise to assess extrahepatic chelostatic liver injury.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25788184     DOI: 10.1007/s12072-014-9595-8

Source DB:  PubMed          Journal:  Hepatol Int        ISSN: 1936-0533            Impact factor:   6.047


  28 in total

Review 1.  CT and MR cholangiography: advantages and pitfalls in perioperative evaluation of biliary tree.

Authors:  T Hyodo; S Kumano; F Kushihata; M Okada; M Hirata; T Tsuda; Y Takada; T Mochizuki; T Murakami
Journal:  Br J Radiol       Date:  2012-03-14       Impact factor: 3.039

2.  CT- and MRI-based volumetry of resected liver specimen: comparison to intraoperative volume and weight measurements and calculation of conversion factors.

Authors:  C Karlo; C S Reiner; P Stolzmann; S Breitenstein; B Marincek; D Weishaupt; T Frauenfelder
Journal:  Eur J Radiol       Date:  2009-09-25       Impact factor: 3.528

3.  Dynamic contrast-enhanced magnetic resonance imaging with Gd-EOB-DTPA for the evaluation of liver fibrosis in chronic hepatitis patients.

Authors:  Bang-Bin Chen; Chao-Yu Hsu; Chih-Wei Yu; Shwu-Yuan Wei; Jia-Horng Kao; Hsuan-Shu Lee; Tiffany Ting-Fang Shih
Journal:  Eur Radiol       Date:  2011-08-31       Impact factor: 5.315

4.  Quantitative evaluation of liver function with use of gadoxetate disodium-enhanced MR imaging.

Authors:  Akira Yamada; Takeshi Hara; Feng Li; Yasunari Fujinaga; Kazuhiko Ueda; Masumi Kadoya; Kunio Doi
Journal:  Radiology       Date:  2011-06-28       Impact factor: 11.105

5.  Comparison of three-dimensional negative-contrast CT cholangiopancreatography with three-dimensional MR cholangiopancreatography for the diagnosis of obstructive biliary diseases.

Authors:  Zhui-Yang Zhang; Dong Wang; Jian-Ming Ni; Xiang-Rong Yu; Lei Zhang; Wen-Juan Wu; Lei Gong; Ming-Hua Hu
Journal:  Eur J Radiol       Date:  2011-03-05       Impact factor: 3.528

6.  Assessment of liver function in primary biliary cirrhosis using Gd-EOB-DTPA-enhanced liver MRI.

Authors:  Henrik Nilsson; Lennart Blomqvist; Lena Douglas; Anders Nordell; Eduard Jonas
Journal:  HPB (Oxford)       Date:  2010-10       Impact factor: 3.647

7.  Dynamic contrast-enhanced magnetic resonance imaging biomarkers predict survival and response in hepatocellular carcinoma patients treated with sorafenib and metronomic tegafur/uracil.

Authors:  Chao-Yu Hsu; Ying-Chun Shen; Chih-Wei Yu; Chiun Hsu; Fu-Chang Hu; Chih-Hung Hsu; Bang-Bin Chen; Shwu-Yuan Wei; Ann-Lii Cheng; Tiffany Ting-Fang Shih
Journal:  J Hepatol       Date:  2011-02-19       Impact factor: 25.083

8.  Staging hepatic fibrosis: comparison of gadoxetate disodium-enhanced and diffusion-weighted MR imaging--preliminary observations.

Authors:  Haruo Watanabe; Masayuki Kanematsu; Satoshi Goshima; Hiroshi Kondo; Minoru Onozuka; Noriyuki Moriyama; Kyongtae T Bae
Journal:  Radiology       Date:  2011-01-19       Impact factor: 11.105

9.  MR imaging evaluation of liver enhancement by Gd-EOB-DTPA in selective and total bile duct obstruction in rats: correlation with serologic, microcholangiographic, and histologic findings.

Authors:  Y Ni; G Marchal; G Lukito; J Yu; A Mühler; A L Baert
Journal:  Radiology       Date:  1994-03       Impact factor: 11.105

10.  MRI assessment of biliary ductal obstruction: is there added value of T1-weighted gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced MR cholangiography?

Authors:  Caecilia S Reiner; Elmar M Merkle; Mustafa R Bashir; Nicholas L Walle; Hamid K Nazeer; Rajan T Gupta
Journal:  AJR Am J Roentgenol       Date:  2013-07       Impact factor: 3.959

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.